Incyte Biosciences International Sàrl

This study is testing the drug ponatinib in children aged 1 to under 18 with advanced leukemias, lymphomas, or solid tumors that have come back or not responded to other treatments. The goal is to see if ponatinib is safe and can shrink or control the cancer. About 70 children wi…